AC
EW icon

Alley Company’s Edwards Lifesciences EW Stock Holding History

Alley Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$266K Hold
2,055
– – 0.04% 78
2021
Q3 		$233K Hold
2,055
– – 0.04% 78
2021
Q2 		$213K Buy
+2,055
New +$194K 0.04% 83

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alley Company's EW Position: Q4 2021 in Review

Alley Company held its Edwards Lifesciences (EW) position steady in Q4 2021 at 2,055 shares worth $266K. The position accounts for 0.04% of the portfolio, ranked #78.

Alley Company first reported a position in EW in Q2 2021 and has held it in 3 quarters since. 1,320 funds tracked by Wall St. Rank hold EW as of Q4 2021.

  • Alley Company held 2,055 shares of Edwards Lifesciences worth $266K as of Q4 2021.
  • Alley Company left its Edwards Lifesciences share count unchanged in Q4 2021.
  • Edwards Lifesciences made up 0.04% of Alley Company's portfolio in Q4 2021, its #78 holding.
  • Alley Company first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 3 quarters since.
  • 1,320 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Alley Company's 13F filing for Q4 2021, filed 25 Jan 2022.